Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Boers

Showing results (211-220 of 308) with videos related to

Pageof 31
Sort By:
The Journal of Rheumatology|May 8, 2003
Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of ErosionsJohn T Sharp, Désirée Van Der Heijde, Maarten Boers, et al.
The Journal of Allergy and Clinical Immunology|March 30, 2022
The HOME Core outcome set for clinical trials of atopic dermatitisHywel C Williams, Jochen Schmitt, Kim S Thomas, et al.
The Journal of Rheumatology|July 17, 2015
14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid ArthritisWalter P Maksymowych, Gilles Boire, Dirkjan van Schaardenburg, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
Arthritis and Rheumatism|October 31, 2009
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective studyMike J L Peters, Vokko P van Halm, Alexandre E Voskuyl, et al.
The Journal of Rheumatology|April 5, 2007
Computer based methods for measurement of joint space width: update of an ongoing OMERACT projectJohn T Sharp, Jane Angwin, Maarten Boers, et al.
The Journal of Rheumatology|February 17, 2015
Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12Lilian H van Tuyl, Martina Sadlonova, Bev Davis, et al.
Rheumatology (Oxford, England)|October 7, 2022
Favourable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trialLinda Hartman, Linda A Rasch, Samina A Turk, et al.
Annals of the Rheumatic Diseases|May 3, 2025
Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trialMaike H M Wientjes, Sadaf Atiqi, Gerrit J Wolbink, et al.
Annals of the Rheumatic Diseases|April 3, 2016
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early diseaseJosef S Smolen, Sabine Collaud Basset, Maarten Boers, et al.
Pageof 31

Showing results (211-220 of 308) with videos related to

Sort By:
Pageof 31
The Journal of Rheumatology|May 8, 2003
Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of ErosionsJohn T Sharp, Désirée Van Der Heijde, Maarten Boers, et al.
The Journal of Allergy and Clinical Immunology|March 30, 2022
The HOME Core outcome set for clinical trials of atopic dermatitisHywel C Williams, Jochen Schmitt, Kim S Thomas, et al.
The Journal of Rheumatology|July 17, 2015
14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid ArthritisWalter P Maksymowych, Gilles Boire, Dirkjan van Schaardenburg, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
Arthritis and Rheumatism|October 31, 2009
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective studyMike J L Peters, Vokko P van Halm, Alexandre E Voskuyl, et al.
The Journal of Rheumatology|April 5, 2007
Computer based methods for measurement of joint space width: update of an ongoing OMERACT projectJohn T Sharp, Jane Angwin, Maarten Boers, et al.
The Journal of Rheumatology|February 17, 2015
Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12Lilian H van Tuyl, Martina Sadlonova, Bev Davis, et al.
Rheumatology (Oxford, England)|October 7, 2022
Favourable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trialLinda Hartman, Linda A Rasch, Samina A Turk, et al.
Annals of the Rheumatic Diseases|May 3, 2025
Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trialMaike H M Wientjes, Sadaf Atiqi, Gerrit J Wolbink, et al.
Annals of the Rheumatic Diseases|April 3, 2016
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early diseaseJosef S Smolen, Sabine Collaud Basset, Maarten Boers, et al.
Pageof 31